Advantage Investment Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Advantage Investment Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-311	Closed	-$6K	–	1077
2018 Q1	$6K	Hold	311	–	–	﹤0.01%	792
2017 Q4	$6K	Hold	311	–	–	﹤0.01%	809
2017 Q3	$4K	Hold	311	–	–	﹤0.01%	876
2017 Q2	$3K	Hold	311	–	–	﹤0.01%	936
2017 Q1	$3K	Sell	311 -6,648	-96%	-$77.2K	﹤0.01%	884
2016 Q4	$94K	Sell	6,959 -1,987	-22%	-$27.7K	0.03%	232
2016 Q3	$110K	Hold	8,946	–	–	0.04%	206
2016 Q2	$98K	Sell	8,946 -1,016	-10%	-$11.4K	0.05%	232
2016 Q1	$109K	Hold	9,962	–	–	0.05%	212
2015 Q4	$172K	Hold	9,962	–	–	0.09%	147
2015 Q3	$198K	Hold	9,962	–	–	0.11%	122
2015 Q2	$164K	Buy	+9,962	New	+$173K	0.08%	160

Advantage Investment Management's SCMP Position: Q2 2018 in Review

Advantage Investment Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2018, closing a stake of 311 shares — an estimated $6K sold.

Advantage Investment Management first reported a position in SCMP in Q2 2015 and held it in 12 quarters. The position peaked at $198K in Q3 2015. 0 funds tracked by Wall St. Rank hold SCMP as of Q2 2018.

Advantage Investment Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
Advantage Investment Management sold 311 Sucampo Pharmaceuticals, Inc. shares in Q2 2018, an estimated $6K.
Advantage Investment Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2015 and held it in 12 quarters.
Advantage Investment Management's Sucampo Pharmaceuticals, Inc. position peaked at $198K in Q3 2015.
0 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2018.

Based on Advantage Investment Management's 13F filing for Q2 2018, filed 13 Aug 2018.